Glaxosmithkline | Resultado Líquido



Net Income Alterar Data
AbbVie USD 938M 348M 2025-06
Amgen USD 1.43B 298M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bausch Health Companies USD 148M 206M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 35.15M 14.6M 2025-06
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 5.66B 2.9B 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
Glaxosmithkline GBP 414M 472M 2024-12
J&J USD 5.54B 5.46B 2025-06
Merck USD 4.43B 652M 2025-06
Novartis USD 4.02B 418M 2025-06
Pacira USD -4847000 9.66M 2025-06
Perrigo USD -8400000 2M 2025-06
Pfizer USD 2.91B 58M 2025-06
Prestige Brands USD 61.78M 11.65M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
Supernus Pharmaceuticals USD 22.5M 34.33M 2025-06
Takeda JPY 124.24B 227.4B 2025-06
Teva Pharmaceutical Industries USD 282M 68M 2025-06
Zoetis USD 718M 87M 2025-06


Glaxosmithkline Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.